Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


SVB Leerink Maintains Underperform on Clovis Oncology, Lowers Price Target to $3


Benzinga | Nov 6, 2020 10:37AM EST

SVB Leerink Maintains Underperform on Clovis Oncology, Lowers Price Target to $3

SVB Leerink maintains Clovis Oncology (NASDAQ:CLVS) with a Underperform and lowers the price target from $4 to $3.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC